Search results for ' APIS'

Amazon's next CEO Andy Jassy's India Plan

Amazon's next CEO Andy Jassy's India Plan

Rediff.com15 May 2021

'We look forward to providing great customer experiences in India.'

Momentum of economic reforms will continue: Sitharaman

Momentum of economic reforms will continue: Sitharaman

Rediff.com23 Nov 2020

Finance Minister Nirmala Sitharaman on Monday assured the industry that momentum of economic reforms will continue to make India a hotspot of global investment. India has turned the crisis created by COVID-19 pandemic into an opportunity to push the economic reforms, which remained pending for decades, she said while addressing the National MNC's Conference 2020 organised by industry chamber CII.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Cadila launches Remdesivir in India at Rs 2,800 per vial

Cadila launches Remdesivir in India at Rs 2,800 per vial

Rediff.com13 Aug 2020

The company said the drug will be made available across India through the group's strong distribution chain reaching out to government and private hospitals treating COVID-19 patients.

Niti Aayog on how India can protect personal data

Niti Aayog on how India can protect personal data

Rediff.com3 Sep 2020

India needs a paradigm shift in personal data management that transforms the current organisation-centric data sharing system to an individual centric approach that promotes user control on data sharing for empowerment, said Niti.

IPL 2020: From shampoo to face masks, brands score a six this season

IPL 2020: From shampoo to face masks, brands score a six this season

Rediff.com5 Oct 2020

Small and big advertisers are making their presence felt this year far more than they did earlier, bringing a smile to the faces of the tournament's organisers and partners.

'Police and politicians are together in the notorious hafta system'

'Police and politicians are together in the notorious hafta system'

Rediff.com24 Mar 2021

'Param Bir's letter alleges that Waze was being used directly by the home minister.' 'I think an enquiry by a high court judge is the need of the hour.'

Govt lifts export ban on anti-malarial drug HCQ

Govt lifts export ban on anti-malarial drug HCQ

Rediff.com18 Jun 2020

Indian Council of Medical Research had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.

Land in Kalapani, Lipulekh belongs to India's border villages

Land in Kalapani, Lipulekh belongs to India's border villages

Rediff.com14 Jun 2020

Local land records also say the land at Kalapani and Lipulekh belongs to the residents of two villages on the Indian side of the border, an official recently said.

Should you invest in these 5 stocks?

Should you invest in these 5 stocks?

Rediff.com26 Aug 2020

These five stocks, which have lagged the markets over the last two years, have doubled in value since March 23.

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Medical devices industry eyes Rs 70,000 cr investment in 5 years

Rediff.com24 May 2020

The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.

Jio Platforms deals a big boost for PE investments

Jio Platforms deals a big boost for PE investments

Rediff.com2 Jul 2020

Investments totaling over $9.5 billion in Jio Platforms by a clutch of private equity firms, following social media giant Facebook's $5.7 billion mid-April investment in the company, helped overall.

Customs to clear pharma raw materials from China

Customs to clear pharma raw materials from China

Rediff.com1 Jul 2020

Apart from them, consignments of 11 top importers, including LG, Samsung, Toyota, Honda, and Siemens, will also be allowed entry, relieving them of the 100 per cent inspection rule.

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

Drug to treat mild, moderate COVID-19 launched in India

Drug to treat mild, moderate COVID-19 launched in India

Rediff.com20 Jun 2020

FabiFlu is the first oral favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir can be used for coronavirus patients with co-morbid conditions such as diabetes and heart disease with mild to moderate COVID-19 symptoms.

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

Glenmark to conduct trials of potential COVID-19 drug

Glenmark to conduct trials of potential COVID-19 drug

Rediff.com30 Apr 2020

As per the clinical trial protocol approved, 150 subjects with mild to moderate COVID-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care. Treatment duration is a maximum of 14 days and the total study duration will be a maximum for 28 days from randomisation.

Hydroxychloroquine exports only to foreign govts, not pvt cos

Hydroxychloroquine exports only to foreign govts, not pvt cos

Rediff.com10 Apr 2020

India will export anti-malarial drug hydroxychloroquine, high in demand globally, only to foreign governments and not to private companies, as the product is under prohibited or banned category of exports, sources said. Although exports of this medicine is completely banned, India has decided to export this anti-malarial drug in sync with its global commitment to deal with the coronavirus pandemic.

In Digital India, SAAS firms are lapping up young execcutives

In Digital India, SAAS firms are lapping up young execcutives

Rediff.com23 Oct 2020

Indian firms selling SAAS products have got a bonanza as companies meet, manage and sell remotely. The top five firms - Zoho, Freshworks HighRadius, Druva, and Icertis - account for 33 per cent of the market share. Chennai, India's SAAS centre, alone generates $1 billion in annual revenue. Yuvraj Malik explains how these companies are planning their next phase of growth.

Every 3rd tablet in the US market is from India

Every 3rd tablet in the US market is from India

Rediff.com9 Jul 2020

India lost its competitive advantage as China gave fiscal benefits to its local manufacturers. Besides, recent policy flip-flops have, however, dented India's image as the 'pharmacy of the world'.

India lifts curbs on exports of 13 active pharma ingredients

India lifts curbs on exports of 13 active pharma ingredients

Rediff.com7 Apr 2020

A leading exporter said, there is enough stock of paracetamol in the country. At present, the US, which has become the epicentre of the COVID-19 outbreak, needs paracetamol. He further said India would lose its credibility as the "pharmacy of the world" if it adopts protectionist policies during such a crisis.

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Wedding in the time of coronavirus, courtesy Pune cops

Wedding in the time of coronavirus, courtesy Pune cops

Rediff.com6 May 2020

The date had been fixed, as was the venue. But what this young couple from Dehradun didn't plan for was the lockdown that prevented them from going back home to get married. Not to worry, the Pune police went out of their way to arrange for a venue, pandit, even for someone to do the kanyadan.

India has so far been able to avoid community transmission: Vardhan

India has so far been able to avoid community transmission: Vardhan

Rediff.com5 May 2020

The nation in a post-coronavirus future could well look back on the pandemic period as a 'blessing in disguise' if Indians imbibe hand, respiratory and environmental hygiene and practise it in their everyday lives, the minister said.

My Top Stock Picks for 2021

My Top Stock Picks for 2021

Rediff.com5 Jan 2021

Three stockmarket experts give their best picks for the New Year.

Reliance gets on WhatsApp to connect buyers to stores

Reliance gets on WhatsApp to connect buyers to stores

Rediff.com27 Apr 2020

Billionaire Mukesh Ambani's Reliance Industries has started a limited test use of WhatsApp to connect customers to grocery stores, days after Facebook decided to invest USD 5.7 billion in digital assets controlled by the company. JioMart, an e-commerce venture of Reliance Retail, "has already started interacting with customers on WhatsApp for grocery orders" in Navi Mumbai, Thane and Kalyan, Credit Suisse said in a report.

Hydroxychloroquine consignment from India arrives in US

Hydroxychloroquine consignment from India arrives in US

Rediff.com12 Apr 2020

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

World's biggest 3D printed building opens in Dubai

World's biggest 3D printed building opens in Dubai

Rediff.com17 Feb 2020

The two-storey 6,900 square foot structure will be used as an office for general administrative functions by the Dubai Municipality. It was designed in collaboration with Apis Cor, a 3D printing and construction company in Boston.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Can we ever keep China out of Indian industries?

Can we ever keep China out of Indian industries?

Rediff.com26 Jun 2020

Experts say while the increasing demand for a ban on Chinese goods might make for good optics, the reality is that India is still heavily dependent on that country in a wide range of industries like electronics, mobile devices, auto, pharma, telecom equipment, and fertilisers.

Coronavirus: No shortage of medicines, says govt

Coronavirus: No shortage of medicines, says govt

Rediff.com5 Mar 2020

'There is no shortage of any APIs (active pharmaceutical ingredients) in the country'

Cadila believes it has silver bullet to fight COVID-19

Cadila believes it has silver bullet to fight COVID-19

Rediff.com21 Apr 2020

Can Interferon alfa-2b treat COVID-19 effectively?

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Timely facilitation of COVID-19 kits will help Sino-India ties: Envoy

Rediff.com14 Apr 2020

As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Coronavirus crisis pushes India to work on drug security

Coronavirus crisis pushes India to work on drug security

Rediff.com26 Mar 2020

The current crisis has forced the government to announce measures to ensure that India becomes self-sustaining for any kind of bulk drug. The government says India will not depend on any other country for vital key ingredients for drugs within six years, reports Sheela Bhatt.

Holding too many stocks in your portfolio?

Holding too many stocks in your portfolio?

Rediff.com20 Oct 2020

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Investments in the time of coronavirus

Investments in the time of coronavirus

Rediff.com9 Mar 2020

Gold, forex assets, IT sector, pharma. Devangshu Datta explains why each of these is a good hedge against market shocks at this time.

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

Hit by data breach? Here's how to reboot your life and control the damage

Hit by data breach? Here's how to reboot your life and control the damage

Rediff.com4 Jan 2020

By the time the security failure is discovered and fixed, the damage is already done. A CIO survey by Forcepoint and Frost & Sullivan found that 69 per cent of Indian organisations were at risk of data breach. Whenever there is data breach, there is a potential disaster waiting to happen.

As China shutdown intensifies, govt plans to rework supply chain

As China shutdown intensifies, govt plans to rework supply chain

Rediff.com24 Feb 2020

To address the supply crunch, CII has suggested leveraging the existing excess capacity in the Indian industry; rolling back import duty hike to look for alternative sources of imports; expanding credit to manufacturing units with quick loan sanctions, and one-time emergency waiver of non-performing asset regulations for three months.